Recovery Unplugged Leads Panel Discussion on Recruitment and Retention at 2024 Mental Health Marketing Conference
10 oct. 2024 11h00 HE
|
Recovery Unplugged
Nashville, TN, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Recovery Unplugged is proud to have participated in the 8th annual Mental Health Marketing Conference (MHMC), held from October 1-3 at The Factory at...
$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment
10 oct. 2024 10h00 HE
|
Unyte Health
The study aims to determine if filtered music as an adjunct therapy can reduce PTSD symptoms and enhance treatment for civilian and military populations.
Monaghan Medical Wins 2024 AARC Zenith Award
03 oct. 2024 04h00 HE
|
Monaghan Medical Corporation
Monaghan Medical Corporation has been honored with the prestigious 2024 Zenith Award from the American Association for Respiratory Care (AARC). This award
Psychiatry Collaboration and Licensing Deals Agreements Report and Directory 2024: Upfront, Milestone, Royalties - Company A-Z, Therapy Focus and Technology Type
30 sept. 2024 05h20 HE
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Psychiatry Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Psychiatry Collaboration and...
Nectero Medical Recognized as a 2024 AZBio Fast Lane Award Winner
24 sept. 2024 08h00 HE
|
Nectero Medical
TEMPE, Ariz., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced today that it received a...
Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs
24 sept. 2024 04h00 HE
|
AKAMPION
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has...
Compass Therapeutics Completes Patient Enrollment in COMPANION-002, a Randomized Study of CTX-009 in Combination with Paclitaxel, and Provides an Update on the Development Plan in Biliary Tract Cancer
06 août 2024 08h00 HE
|
Compass Therapeutics
Completed enrollment of the planned 150 patients in COMPANION-002, a Phase 2/3 trial of CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced Metastatic...
Global Anxiety Disorder Treatment Analysis Report 2024: Market to Surpass $12 Billion by 2030 - Consumer Preference for Non-Pharmacological Treatments Drives Adoption of Alternative Therapies
17 juil. 2024 10h21 HE
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Anxiety Disorder Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Valley Spring Recovery Center Enhances Addiction Treatment with Matrix Model, Integrating Holistic Therapies in Norwood
28 juin 2024 16h53 HE
|
Valley Spring Recovery Center
Norwood, NJ, June 28, 2024 (GLOBE NEWSWIRE) -- Valley Spring Recovery Center, trusted by many and accredited by major behavioral healthcare licensing bodies, continues to explore modern and more...
Global Mental Health Screening Market Size To Worth USD 2.62 Billion By 2033 l CAGR of 11.78%
18 juin 2024 16h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , June 18, 2024 (GLOBE NEWSWIRE) -- The Global Mental Health Screening Market Size is to Grow from USD 0.86 Billion in 2023 to USD 2.62 Billion by 2033, at a Compound Annual...